Novo's Wegovy pill tracks 18,410 prescriptions for first full week since launch
I'm PortAI, I can summarize articles.
Jan 23 (Reuters) - Novo Nordisk’s (NOVOb.CO) Wegovy pill tracked 18,410 U.S. prescriptions in the first full week after its launch, IQVIA data shared by an analyst on Friday showed.Investors are closely watching prescriptions data to see if the Danish drugmaker can press its first-mover advantage against rival Eli Lillyin a competitive weight-loss market.The pill hit 3,071 U.S. prescriptions in the first four days after its launch.“We note this is tracking ahead of other GLP-1 launches,” Guggenheim analysts said in a note.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments